A multicenter randomized trial comparing the effectiveness and safety of a novel vascular closure device to manual compression in anticoagulated patients undergoing percutaneous transfemoral procedures: The Celt ACD trial Academic Article uri icon

Overview

MeSH Major

  • Coronary Artery Bypass
  • Coronary Artery Disease
  • Hospital Mortality
  • Mammary Arteries
  • Postoperative Complications

abstract

  • After 6-F percutaneous invasive procedures in fully anticoagulated patients, TTH was significantly reduced in patients assigned to Celt ACD(®) compared to patients managed with MC. The 30-day rates of vascular complications were similarly low in both groups. (CELT ACD Trial; NCT01600482) © 2017 Wiley Periodicals, Inc.

publication date

  • January 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/ccd.26991

PubMed ID

  • 28296003